2m 2m 2m 2m 2m 2m 2m
DRUGS MADE (DMAA)
NASDAQ
$10.79-$0.01 (-0.09%)
Price as of Sep 11, 2026 4:00 PM EDT- N/AMarket Cap
- 4.85%1-Year Change
- Shell CompaniesIndustry
DRUGS MADE (DMAA)
$10.79-$0.01 (-0.09%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
KARPUS MANAGEMENT, INC. | 10.33% | 2.5M | -22,700 (-0.91%) | Jun 30, 2026 |
MIZUHO SECURITIES USA LLC | 8.52% | 2.1M | +69,605 (+3.36%) | Jun 30, 2026 |
POLAR ASSET MANAGEMENT PARTNERS INC. | 4.72% | 1.1M | -454,000 (-39.62%) | Jun 30, 2026 |
GLAZER CAPITAL, LLC | 4.12% | 999,899 | -678,507 (-67.86%) | Jun 30, 2026 |
CROSSINGBRIDGE ADVISORS, LLC | 3.50% | 850,000 | +850,000 (+100.00%) | Mar 31, 2025 |
WOLVERINE ASSET MANAGEMENT LLC | 3.43% | 832,093 | -721,615 (-86.72%) | Jun 30, 2026 |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3.33% | 809,054 | -514,297 (-63.57%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
Investment Managers Series Trust II | 3.21% | 780,449 | -1.4M (-185.63%) | Jun 30, 2026 |
Current Ownership Distribution
- Institutions119.6M (80.14%)
- Mutual Funds20.8M (13.97%)
- Insiders8.8M (5.88%)
- Other0 (0.00%)
Insider Transactions
- 5.88% (8.8M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Drugs Made In America Acquisition LLC | Buy | Feb 18, 2025 | $0.00 | 30,000 | $0.00 | 430,000 |
Stockwell Lynn CEO and Exe. Chair of Board | Buy | Feb 18, 2025 | $0.00 | 30,000 | $0.00 | 430,000 |
Drugs Made In America Acquisition LLC | Buy | Feb 18, 2025 | $0.00 | 30,000 | $0.00 | 4.2M |
Stockwell Lynn CEO and Exe. Chair of Board | Buy | Feb 18, 2025 | $0.00 | 30,000 | $0.00 | 4.2M |
Shulgan Myron W. | Other | Jan 29, 2025 | $0.00 | 100,000 | $0.00 | 100,000 |
Prasad Sridhar G. | Other | Jan 29, 2025 | $0.00 | 100,000 | $0.00 | 100,000 |
Worman Glenn C. CFO | Other | Jan 29, 2025 | $0.00 | 100,000 | $0.00 | 100,000 |
Do Catherine | Other | Jan 29, 2025 | $0.00 | 100,000 | $0.00 | 100,000 |
Drugs Made In America Acquisition LLC | Buy | Jan 29, 2025 | $0.00 | 400,000 | $0.00 | 400,000 |
Stockwell Lynn CEO and Executive COB | Buy | Jan 29, 2025 | $0.00 | 400,000 | $0.00 | 400,000 |
Drugs Made In America Acquisition LLC | Buy | Jan 29, 2025 | $0.00 | 400,000 | $0.00 | 10.3M |
Stockwell Lynn CEO and Executive COB | Buy | Jan 29, 2025 | $0.00 | 400,000 | $0.00 | 10,257 |
Drugs Made In America Acquisition LLC | Other | Jan 29, 2025 | $0.00 | 400,000 | $0.00 | 9.9M |
Stockwell Lynn CEO and Executive COB | Other | Jan 29, 2025 | $0.00 | 400,000 | $0.00 | 9.9M |
Drugs Made In America Acquisition LLC | Sell | Jan 29, 2025 | $0.00 | 5.7M | $0.00 | 4.2M |
Stockwell Lynn CEO and Executive COB | Sell | Jan 29, 2025 | $0.00 | 5.7M | $0.00 | 4.2M |